Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
97.432,70
-0,33%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Opko Health Inc (OPK) Opko Health Inc (OPK) Notizie

OPK

Opko Health (OPK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OPK
DataOraFonteTitoloSimboloCompagnia
10/12/202414:00PR Newswire (US)NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online RetailerNASDAQ:OPKOpko Health Inc
21/11/202403:36Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:OPKOpko Health Inc
20/11/202414:00GlobeNewswire Inc.OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:OPKOpko Health Inc
18/11/202414:00PR Newswire (US)NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition ExpoNASDAQ:OPKOpko Health Inc
14/11/202412:00PR Newswire (US)NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 ResultsNASDAQ:OPKOpko Health Inc
13/11/202422:30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:OPKOpko Health Inc
08/11/202422:05GlobeNewswire Inc.Entera Bio Reports Q3 2024 Financial Results and Provides Business UpdatesNASDAQ:OPKOpko Health Inc
07/11/202422:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
07/11/202422:05GlobeNewswire Inc.OPKO Health Reports Third Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
07/11/202414:00GlobeNewswire Inc.Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®NASDAQ:OPKOpko Health Inc
29/10/202421:05GlobeNewswire Inc.OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024NASDAQ:OPKOpko Health Inc
07/10/202414:00PR Newswire (US)NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into JapanNASDAQ:OPKOpko Health Inc
07/10/202414:00GlobeNewswire Inc.ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza ProgramNASDAQ:OPKOpko Health Inc
25/09/202414:30GlobeNewswire Inc.Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic DisordersNASDAQ:OPKOpko Health Inc
23/09/202414:00GlobeNewswire Inc.OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical DevelopmentNASDAQ:OPKOpko Health Inc
20/09/202420:56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPKOpko Health Inc
16/09/202413:30PR Newswire (US)Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO HealthNASDAQ:OPKOpko Health Inc
30/08/202423:01Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:OPKOpko Health Inc
19/08/202423:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
09/08/202422:05GlobeNewswire Inc.Entera Bio Reports Q2 2024 Financial Results and Provides Business UpdatesNASDAQ:OPKOpko Health Inc
07/08/202422:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPKOpko Health Inc
07/08/202422:06GlobeNewswire Inc.OPKO Health Reports Second Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
01/08/202422:05GlobeNewswire Inc.OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024NASDAQ:OPKOpko Health Inc
18/07/202414:00GlobeNewswire Inc.OPKO Health Announces $100 Million Share Repurchase ProgramNASDAQ:OPKOpko Health Inc
17/07/202422:14GlobeNewswire Inc.OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share PaymentsNASDAQ:OPKOpko Health Inc
02/07/202414:00PR Newswire (US)NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing PartnerNASDAQ:OPKOpko Health Inc
31/05/202416:48GlobeNewswire Inc.OPKO Health to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:OPKOpko Health Inc
07/05/202422:05GlobeNewswire Inc.OPKO Health Reports First Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
03/05/202414:00GlobeNewswire Inc.OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:OPKOpko Health Inc
28/03/202413:00PR Newswire (US)Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessNASDAQ:OPKOpko Health Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OPK

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
SPM
Saipem
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
RACE
Ferrari NV
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
FBK
Finecobank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network